Valuation: ALTEOGEN Inc.

Market Cap 21,238B 15.07B 13.03B 12.17B 11.17B 21B 1,434B 21.33B 143B 56.05B 719B 56.58B 55.34B 2,376B P/E 2026 *
63x
P/E 2027 * 45.3x
Enterprise Value 20.72B 14.7M 12.72M 11.88M 10.9M 20.49M 1.4B 20.82M 139M 54.69M 701M 55.21M 54.01M 2.32B EV / Sales 2026 *
42.9x
EV / Sales 2027 * 29.6x
Free-Float
57.13%
Yield 2026 *
0.14%
Yield 2027 * 0.13%
1 day+3.92%
1 week+28.53%
Current month+28.53%
1 month+26.48%
3 months+16.45%
6 months+9.83%
Current year-11.79%
1 week 231,923.08
Extreme 231923.076923
308,000
1 month 194,615.38
Extreme 194615.384615
308,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 32,346.15
Extreme 32346.153846
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap.
21/05/25 Fiscal year

Chief Executive Officer

7,200 0.0135%
27/03/24 Sell 1,600,000 3.0182%
05/01/24 Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
+3.92%+28.53%-7.79%+782.09% 15.07B
+1.59%+2.85%+39.32%+0.52% 78.32B
+2.77%+4.78%-0.98%+28.10% 51.1B
-0.84%+0.09%+20.92%+175.02% 49.18B
-0.13%+7.42%-49.33%-50.09% 44.71B
+0.80%+2.46%+59.13%-24.15% 30.72B
+1.84%+0.87%+53.80%+86.83% 24.44B
+9.86%+7.94%+126.53%-40.68% 23.62B
+4.29%+9.40%+3.95%+230.49% 21.05B
+1.66%-3.70%+66.13%+121.72% 16.61B
Average +2.58%+6.16%+31.17%+130.99% 35.48B
Weighted average by Cap. +1.97%+5.17%+25.47%+75.87%

Financials

2026 *2027 *
Net sales 484B 343M 297M 277M 254M 478M 32.65B 486M 3.25B 1.28B 16.36B 1.29B 1.26B 54.1B 688B 488M 422M 394M 362M 680M 46.45B 691M 4.63B 1.82B 23.28B 1.83B 1.79B 76.98B
Net income 311B 220M 191M 178M 163M 307M 20.98B 312M 2.09B 820M 10.51B 828M 810M 34.76B 397B 281M 243M 227M 208M 392M 26.78B 398M 2.67B 1.05B 13.42B 1.06B 1.03B 44.37B
Net Debt -514B -365M -315M -295M -270M -508M -34.7B -516M -3.46B -1.36B -17.39B -1.37B -1.34B -57.5B -843B -598M -518M -483M -443M -834M -56.94B -847M -5.67B -2.23B -28.54B -2.25B -2.2B -94.36B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
07/08/26 ₩305,000.00 +3.92% 495,569
06/08/26 ₩293,500.00 +5.96% 764,630
05/08/26 ₩277,000.00 +3.78% 637,092
04/08/26 ₩266,923.08 +9.29% 743,563
03/08/26 ₩244,230.77 +2.92% 392,174
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
305,000.00KRW
Average target price
370,897.44KRW
Spread / Average Target
+21.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock